Guidant’s Problems Go Beyond Bad Communication – Boston Scientific CEO
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific will overhaul product design at recently acquired Guidant to prevent the recurrence of malfunctioning pacemakers and implantable defibrillators
You may also be interested in...
Boston Scientific Initiates Another ICD Battery Depletion Recall
Boston Scientific is warning customers that batteries in 73,000 of its implantable cardioverter defibrillators could run out faster than indicated on their label
Boston Scientific Initiates Another ICD Battery Depletion Recall
Boston Scientific is warning customers that batteries in 73,000 of its implantable cardioverter defibrillators could run out faster than indicated on their label
Medtronic Loses ICD Market Share, Looks Ahead To U.S. Market Rebound
Medtronic is optimistic about a recovery in the implantable cardioverter defibrillator market, despite lower-than-expected sales in its most recent fiscal quarter, reported Feb. 20